About Us
is a biotech company focused on developing cell & gene therapies to patients and doctors worldwide. One of our projects aims to create the world's first CAR-T cancer therapy ready for immediate administration, based on an allogeneic populational bank.
CAR-T is a groundbreaking technology combining cell therapy and genetic engineering. Patients with hematological cancers have the chance to be treated with T lymphocytes, which, after genetic modification, become tools of the most advanced immunotherapy available today.
